Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Other financing activities (2018 - 2025)

TELA Bio (TELA) has 6 years of Other financing activities data on record, last reported at $21000.0 in Q3 2025.

  • For Q3 2025, Other financing activities rose 10.53% year-over-year to $21000.0; the TTM value through Sep 2025 reached $212000.0, down 41.44%, while the annual FY2024 figure was $369000.0, 27.68% up from the prior year.
  • Other financing activities reached $21000.0 in Q3 2025 per TELA's latest filing, up from $3000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $3.2 million in Q2 2022 and bottomed at -$3.2 million in Q3 2022.
  • Average Other financing activities over 4 years is $72571.4, with a median of $15000.0 recorded in 2024.
  • Peak YoY movement for Other financing activities: tumbled 99.97% in 2023, then skyrocketed 1000.0% in 2024.
  • A 4-year view of Other financing activities shows it stood at -$3.2 million in 2022, then skyrocketed by 100.12% to $4000.0 in 2023, then skyrocketed by 175.0% to $11000.0 in 2024, then surged by 90.91% to $21000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other financing activities were $21000.0 in Q3 2025, $3000.0 in Q2 2025, and $177000.0 in Q1 2025.